Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Certification in reporting multiparametric magnetic resonance imaging of the prostate: recommendations of a UK consensus meeting.
Barrett T, Padhani AR, Patel A, Ahmed HU, Allen C, Bardgett H, Belfield J, Brizmohun Appayya M, Harding T, Hoch OS, Keanie JY, Liyanage SH, Papoutsaki MV, Punwani S, Robinson MJC, Rajesh A, Stafurth JN, van der Meulen J, Richenberg J. Barrett T, et al. Among authors: liyanage sh. BJU Int. 2021 Mar;127(3):304-306. doi: 10.1111/bju.15285. Epub 2020 Nov 16. BJU Int. 2021. PMID: 33113258 No abstract available.
The CADMUS trial - Multi-parametric ultrasound targeted biopsies compared to multi-parametric MRI targeted biopsies in the diagnosis of clinically significant prostate cancer.
Grey A, Scott R, Charman S, van der Meulen J, Frinking P, Acher P, Liyanage S, Madaan S, Constantinescu G, Shah B, Graves CB, Freeman A, Jameson C, Ramachandran N, Emberton M, Arya M, Ahmed HU. Grey A, et al. Contemp Clin Trials. 2018 Mar;66:86-92. doi: 10.1016/j.cct.2017.10.011. Epub 2017 Nov 3. Contemp Clin Trials. 2018. PMID: 29108869 Free article.
The "Is mpMRI Enough" or IMRIE Study: A Multicentre Evaluation of Prebiopsy Multiparametric Magnetic Resonance Imaging Compared with Biopsy.
Stonier T, Simson N, Shah T, Lobo N, Amer T, Lee SM, Bass E, Chau E, Grey A, McCartan N, Acher P, Ahmad I, Arumainayagam N, Brown D, Chapman A, Elf D, Hartington T, Ibrahim I, Leung H, Liyanage S, Lovegrove C, Malthouse T, Mateen B, Mistry K, Morrison I, Nalagatla S, Persad R, Pope A, Sokhi H, Syed H, Tadtayev S, Tharmaratnam M, Qteishat A, Miah S, Emberton M, Moore C, Walton T, Eddy B, Ahmed HU. Stonier T, et al. Eur Urol Focus. 2021 Sep;7(5):1027-1034. doi: 10.1016/j.euf.2020.09.012. Epub 2020 Oct 10. Eur Urol Focus. 2021. PMID: 33046412
Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory study.
Grey ADR, Scott R, Shah B, Acher P, Liyanage S, Pavlou M, Omar R, Chinegwundoh F, Patki P, Shah TT, Hamid S, Ghei M, Gilbert K, Campbell D, Brew-Graves C, Arumainayagam N, Chapman A, McLeavy L, Karatziou A, Alsaadi Z, Collins T, Freeman A, Eldred-Evans D, Bertoncelli-Tanaka M, Tam H, Ramachandran N, Madaan S, Winkler M, Arya M, Emberton M, Ahmed HU. Grey ADR, et al. Lancet Oncol. 2022 Mar;23(3):428-438. doi: 10.1016/S1470-2045(22)00016-X. Lancet Oncol. 2022. PMID: 35240084 Clinical Trial.
Perineal recurrence of prostate cancer post-brachytherapy.
Cooper S, Pillinger T, Ahmed I, Wolfe K, Liyanage S. Cooper S, et al. BJR Case Rep. 2019 Apr 29;5(3):20180104. doi: 10.1259/bjrcr.20180104. eCollection 2019 Sep. BJR Case Rep. 2019. PMID: 31555469 Free PMC article.
43 results